The study questioned whether a low dose of tissue plasminogen activator 0.5 mg/kg (max 50 mg), given as a 10 mg bolus, followed by a drip over two hours, would lead to differences in rates of pulmonary hypertension, mortality, and bleeding. This evidence concerns the gene PLAT and pulmonary arterial hypertension.